BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanning N, Edwinson AL, Ceuleers H, Peters SA, De Man JG, Hassett LC, De Winter BY, Grover M. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review. Therap Adv Gastroenterol 2021;14:1756284821993586. [PMID: 33717210 DOI: 10.1177/1756284821993586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kleppe MM, Brønstad I, Lied GA, Danielsen Y, Rekkedal GÅ, Kessler U. Intestinal barrier integrity in anorexia nervosa (a pilot study). Int J Eat Disord 2022. [PMID: 35040160 DOI: 10.1002/eat.23678] [Reference Citation Analysis]
2 Luo X, Huo X, Zhang Y, Cheng Z, Chen S, Xu X. Increased intestinal permeability with elevated peripheral blood endotoxin and inflammatory indices for e-waste lead exposure in children. Chemosphere 2021;279:130862. [PMID: 34134434 DOI: 10.1016/j.chemosphere.2021.130862] [Reference Citation Analysis]
3 Pretorius L, Van Staden ADP, Van der Merwe JJ, Henning N, Smith C. Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome. Inflammopharmacology 2022. [PMID: 35022916 DOI: 10.1007/s10787-021-00906-8] [Reference Citation Analysis]
4 Friesen C, Colombo JM, Deacy A, Schurman JV. An Update on the Assessment and Management of Pediatric Abdominal Pain. Pediatric Health Med Ther 2021;12:373-93. [PMID: 34393542 DOI: 10.2147/PHMT.S287719] [Reference Citation Analysis]
5 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yue B, Gao R, Lv C, Yu Z, Wang H, Geng X, Wang Z, Dou W. Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase. Front Pharmacol 2021;12:774560. [PMID: 34795594 DOI: 10.3389/fphar.2021.774560] [Reference Citation Analysis]
7 Malnick SDH, Fisher D, Somin M, Neuman MG. Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. Biology (Basel) 2021;10:447. [PMID: 34065241 DOI: 10.3390/biology10050447] [Reference Citation Analysis]
8 Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines 2022;10:289. [DOI: 10.3390/biomedicines10020289] [Reference Citation Analysis]
9 Kasti A, Petsis K, Lambrinou S, Katsas K, Nikolaki M, Papanikolaou IS, Hatziagelaki E, Triantafyllou K. A Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut! Microorganisms 2022;10:751. [DOI: 10.3390/microorganisms10040751] [Reference Citation Analysis]
10 Salinas E, Reyes-Pavón D, Cortes-Perez NG, Torres-Maravilla E, Bitzer-Quintero OK, Langella P, Bermúdez-Humarán LG. Bioactive Compounds in Food as a Current Therapeutic Approach to Maintain a Healthy Intestinal Epithelium. Microorganisms 2021;9:1634. [PMID: 34442713 DOI: 10.3390/microorganisms9081634] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Van Spaendonk H, Ceuleers H, Smet A, Berg M, Joossens J, Van der Veken P, Francque SM, Lambeir AM, De Man JG, De Meester I, Augustyns K, De Winter BY. The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model. Front Pharmacol 2021;12:682065. [PMID: 34248633 DOI: 10.3389/fphar.2021.682065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Reference Citation Analysis]
13 Moonwiriyakit A, Pathomthongtaweechai N, Steinhagen PR, Chantawichitwong P, Satianrapapong W, Pongkorpsakol P. Tight junctions: from molecules to gastrointestinal diseases. Tissue Barriers 2022;:2077620. [PMID: 35621376 DOI: 10.1080/21688370.2022.2077620] [Reference Citation Analysis]
14 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Reference Citation Analysis]
15 Paine P. Review article: current and future treatment approaches for pain in IBS. Aliment Pharmacol Ther 2021;54 Suppl 1:S75-88. [PMID: 34927753 DOI: 10.1111/apt.16550] [Reference Citation Analysis]
16 Elbadawi M, Ammar RM, Aziz-Kalbhenn H, Rabini S, Klauck SM, Dawood M, Saeed MEM, Kampf CJ, Efferth T. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. Phytomedicine 2021;88:153589. [PMID: 34111617 DOI: 10.1016/j.phymed.2021.153589] [Cited by in F6Publishing: 1] [Reference Citation Analysis]